Molecular Imaging: Page 74

GE gets clearance for additional uses for stress contrast agent

By AuntMinnie.com staff writers

GE Healthcare has secured clearance from the European Medicines Agency for additional imaging modalities for its Rapiscan stress contrast agent.

February 13, 2022

NRC plans to develop rubidium-82 generator requirements

By AuntMinnie.com staff writers

The U.S. Nuclear Regulatory Commission (NRC) recently approved rulemaking that would add performance-based requirements for rubidium-82 generators.

February 10, 2022

Shine and Telix ink Lu-177 supply deal

By AuntMinnie.com staff writers

Medical isotope company Shine Technologies and Telix Pharmaceuticals have signed an agreement covering the supply of lutetium-177 (Lu-177) to Telix for clinical development of potential new therapeutics to treat prostate and kidney cancer.

February 9, 2022

MET-PET useful for diagnosing childhood brain tumors

By Will Morton

Brain PET imaging with carbon-11 methionine may be an effective new approach for identifying developmental brain tumors in children and adolescents, according to a study published February 7 in PLOS One.

February 9, 2022

PET/CT proves value diagnosing fevers of unknown origin

By Will Morton

F-18 FDG PET/CT is effective for diagnosing fevers of unknown origin in more than half of cases after other imaging approaches have failed, according to a study published February 3 in Scientific Reports.

February 8, 2022

Navidea inks research deal with Univ. of Pennsylvania

By AuntMinnie.com staff writers

Radiopharmaceutical developer Navidea Biopharmaceuticals has signed an agreement with the University of Pennsylvania to evaluate its technetium-99m tilmanocept radiopharmaceutical as a prognostic agent in glioblastoma.

February 7, 2022

PET/MRI appears safe for pregnant women

By Will Morton

A study by researchers from the U.S. National Cancer Institute has shown that hybrid PET/MR imaging exams in pregnant women pose little risk of harmful radiation exposure to the fetus. The results were published online February 3 in the Journal of Nuclear Medicine.

February 7, 2022

Shine secures funding for design of new isotope facility

By AuntMinnie.com staff writers

Medical isotope firm Shine Medical Technologies has secured funding for its planned new medical isotope manufacturing facility in Veendam, the Netherlands.

February 3, 2022

Isotope shortage expected to last weeks

By AuntMinnie.com staff writers

Shortages of global supplies of molybdenum-99 and lutetium-177 may be inevitable until approximately mid-February due to a recent shutdown of a nuclear reactor in Petten, the Netherlands, according to Nuclear Medicine Europe.

February 3, 2022

Germany's ITM announces key appointments

By AuntMinnie.com staff writers

German radiopharmaceutical biotechnology company ITM Isotope Technologies Munich has appointed three executives to lead the vendor's expansion in the U.S.

February 3, 2022

PET tracer shows brain activity in early Alzheimer's disease

By Will Morton

Researchers have developed a PET radiotracer that reveals activity in brain cells that may be involved in the early stages of Alzheimer's disease, according to a study published January 27 in the Journal of Nuclear Medicine.

February 3, 2022

Polish nuclear reactor fills gap caused by Dutch reactor fault

By AuntMinnie.com staff writers

The Maria nuclear reactor in Poland filled the gap in medical molybdenum-99 production caused by a fault discovered in the Dutch Petten High Flux Reactor reactor.

January 31, 2022

Previous Page

Page 74 of 611

Next Page